The Swedish Public Health Agency is now updating its views on the spread of the disease in Sweden until 20 March 2022. This is due to the strong prevalence of the Omigron virus variant. In recent weeks, knowledge of Omigron and its ability to break down previous immune defenses has been gained. Among other things, preliminary results from the United Kingdom and Denmark show that protection against infection after a second vaccine dose, as well as after a recent infection, is lower against Omigrans than previously thought. Developments in Sweden follow in the footsteps of many countries in Europe such as the United Kingdom, the Netherlands and Denmark, where omigrans have led to a sharp increase in the spread of the disease.

Peaks at the end of January

Estimates in the Public Health Agency’s updated footage indicate that there is still a sharp increase in the spread of the infection for two more weeks, peaking at the end of January. Although vaccinated individuals have good protection against acute illness for at least six months after the second dose, it is estimated that the burden on health care will increase despite the fact that infection with the Omigran variant generally reduces the risk of serious illness. Vaccine coverage now stands at 82.5 percent for people 12 years of age and older, but 1.2 million people in Sweden are still unvaccinated.

– The spread of the disease continues to increase sharply and we are in a serious situation where it has not yet reached a climax. It is important that everyone accepts the possibility of vaccination and follows current regulations and advice to minimize contact in the population. State epidemiologist Anders Technell says it is important for everyone to accept their responsibility for how well we are succeeding in slowing the spread of the infection and minimizing its effects.

See also  Tic Tac Toe star Sam Ryder for Eurovision song contest

Updated views

The scenarios presented now should not be considered forecasts, but illustrate potential growth. The purpose is to assist them in planning health resources. As with previous scenes there is uncertainty about the development, this time especially the knowledge about Omigron is still under construction.

Display 0

After two and three doses, respectively, the effect of the vaccine against omigran infection is estimated to be 20 and 70 percent, respectively. The number of new cases during the peak of the epidemic is estimated at about 47,000 a day.

Scene 1

After two and three doses, respectively, the effect of the vaccine against omigran infection is estimated to be 20 and 35 percent, respectively. The number of new cases during the peak of the epidemic is estimated at about 69,000 a day.

The calculations in the footage have been made, among other things, based on the cases reported up to 6 January 2022 and including.

Read more

Views for continued dissemination – Interim Report January 2022

Category: News